DJIA 17,226.31 34.94 0.20%
NASDAQ 4,621.57 -16.43 -0.35%
S&P 500 1,999.52 -2.64 -0.13%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

31.39 -0.35 (-1.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $31.39 -1.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.76
Previous Close $31.74
Daily Range $31.07 - $31.96
52-Week Range $30.05 - $55.99
Market Cap $3.9B
P/E Ratio -61.03
Dividend (Yield) $0.00 (0.0%)
Volume 352,637
Average Daily Volume 1,369,800
Current FY EPS -$0.66





Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

See More SGEN News...

SGEN's Top Competitors

SGEN $31.39 (-1.09%)
Current stock: SGEN
AMGN $154.48 (-0.10%)
Current stock: AMGN
GILD $103.23 (0.76%)
Current stock: GILD
BIIB $347.25 (-1.12%)
Current stock: BIIB